Atlas Trials

A Study to Investigate the Bioequivalence of Lacosamide 200mg Administered as Intravenous Solution and Oral Tablet in Healthy Chinese Male Subjects

Clinical trial NCT03204474 · COMPLETED

Trial details

NCT number
NCT03204474
Sponsor
UCB Biopharma S.P.R.L.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Male Chinese Volunteers
Start date
2017-06-08
Primary completion
2017-07-28
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.